Oystershell NV   Report issue

For profit
Founded: Drongen United States (1979)
Status: No NME R&D (1979)

Organization Overview

First Clinical Trial
2007
NCT00672971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Oystershell NV

Active Ingredients

Drugs in Other Trials (4)

Amorolfine (loceryl) (3 trials)

permethrin (nix) (2 trials)

pyrethrum (2 trials)

x92001327 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 7
  • # of Trial APIs: 4